Peer Review History

Original SubmissionSeptember 3, 2024
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Decision Letter - Antonio Peña-Fernández, Editor

PONE-D-24-38287Enabling Transparent Toxicokinetic Modeling for Public Health Risk AssessmentPLOS ONE

Dear Dr. Wambaugh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for considering our journal for publication of your manuscript. Your manuscript has now been peer-reviewed, could you please take their comments into account and submit a revised version of your manuscript for our consideration?

Please submit your revised manuscript by Feb 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Antonio Peña-Fernández, PhD

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

[The United States Environmental Protection Agency (EPA) through its Office of Research and Development (ORD) funded the research described here. This project was supported by appointments to the Internship/Research Participation Program at ORD and administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and U.S. EPA. J.P.S acknowledges funding support from the U.S. EPA in grant USEPA RD840027].

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf."

3. Please expand the acronym “ U.S. EPA” (as indicated in your financial disclosure) so that it states the name of your funders in full.

This information should be included in your cover letter; we will change the online submission form on your behalf.

4. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories .

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

Additional Editor Comments:

Dear authors,

Thank you for considering our journal for publication of your manuscript. Your manuscript has now been peer-reviewed, could you please take their comments into account and submit a revised version of your manuscript for our consideration?

Best wishes,

Antonio

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript describes the integration and evaluation of new PBTK models into an existing R package (httk) in order to improve in vitro to in vivo extrapolation, which is critical for human health risk assessment. The manuscript is written exceptionally well with clear referals to case studies and model performance evaluations. The manuscript also addresses limitations of the existing package and the improvements that will be implemented by the authors. I do not have any major queries that would impact on the current standard of the manuscript and would therefore suggest acceptance of the manuscript without revision.

Reviewer #2: This manuscript describes the process of adding new TK models to the httk R package. The topic is relevant, particularly given the increasing reliance on in vitro and in silico methods for chemical risk assessment. While the manuscript provides a valuable overview of httk and its functionalities, several major revisions are needed to enhance clarity, accessibility, and impact. Specifically, the manuscript needs to be more concise and focused on the practical aspects of model integration, with less emphasis on background information already available elsewhere. A more concrete and worked-through example is essential for readers to grasp the process.

Major Revisions:

Streamline the Introduction: The introduction is lengthy and contains substantial background on HTTK and risk assessment that could be condensed or removed. Focus on the specific gap this manuscript addresses – the need for clear guidelines on integrating new models into httk – and the benefits of doing so (e.g., community contributions, model standardization, improved reproducibility).

Simplify and Refocus the Results Section: The current results section blends model integration details with evaluation results. Separate these clearly. The re-evaluation of the Linakis et al. model is interesting but distracts from the core purpose of the manuscript. Either move this to a supplementary document or significantly shorten it, focusing on specific changes and their impact on RMSLE. Emphasize the practical implications of observed changes for model developers. The discussion of benchmark_httk() is more appropriate for the methods.

Provide a Concrete, Worked-Through Example: The most significant weakness is the lack of a clear, step-by-step example. While the gas inhalation model is mentioned and supplementary files are provided, the manuscript doesn't guide the reader through the process of integration. Include a simplified, illustrative example within the main text, demonstrating the creation of a basic model (even a one-compartment model) and its integration into httk. Show concrete code snippets and explain the purpose of each step. This example should be the central focus of the manuscript.

Reorganize the Methods Section: The methods section is currently quite dense and difficult to follow. Reorganize it into more logical subsections with clear headings, following the steps of model integration described in Table 1. Each subsection should describe the specific tasks involved in that step, the relevant httk functions and data, and provide short, illustrative code examples where appropriate. Move the discussion of benchmark_httk() from the Results to the "Model Evaluation" subsection of the Methods.

Clarify the Role of MCSim: The manuscript mentions using MCSim for model description but doesn't clearly explain its advantages or provide enough guidance on its use. Expand this discussion and provide a simple MCSim example within the worked-through example mentioned above. If the authors intend to encourage MCSim use for new httk model contributions, this warrants more attention.

Improve Table and Figure Presentation: Several tables are overly complex and could be simplified or broken down. Table 2, in particular, is very dense. Consider splitting it into smaller, more focused tables. Figures 3, 4, and 5 are helpful but could benefit from clearer labels and more concise captions.

Reduce Redundancy: There is some redundancy in the manuscript, particularly regarding the descriptions of core functions and data tables. Streamline these discussions and avoid repeating information already presented in the tables.

Clarify the Intended Audience: Is this manuscript intended for experienced modelers, R users, or a broader audience? Clarify the intended audience and adjust the level of detail and explanation accordingly.

Minor Revisions:

Carefully proofread the manuscript for typos and grammatical errors.

Ensure consistency in terminology and abbreviations.

Provide more context and explanation for equations and mathematical concepts.

Double-check the accuracy of all URLs and references.

By addressing these major revisions, the manuscript can be significantly improved and provide a truly practical and accessible guide for integrating new TK models into httk, fostering community contributions and advancing the field of HTTK modeling

Reviewer #3: - Please remove the quote from the end of the Introduction section. While Dr Feynman is the best, and I absolutely love the quote itself, it seems out of place and unnecessary here.

- A lot of the Methods section feels like it belongs in the Supplementary section

Reviewer #4: In their present work, Sarah et al. describe the integration and evaluation of new physiologically based toxicokinetic (PBTK) models into an open-source R package. The research is robust, the manuscript is well-structured, and the authors have meticulously detailed each step of the model development process. I would like to offer a few suggestions to further enhance the manuscript:

1. Abstract: The abstract is quite lengthy. It would be beneficial to make it more concise while retaining the essential details.

2. It would be helpful if the authors could discuss whether a similar tool is available in other programming languages, such as Python.

3.The resolution of Figure 2 is quite low. Replacing it with a higher-resolution image would significantly improve its clarity and visual appeal.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: Yes:  Xuehai Wang

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Rebuttal Letter PONE-D-24-38287

Enabling Transparent Toxicokinetic Modeling for Public Health Risk Assessment

A rebuttal letter responds to each point raised by the academic editor and reviewer(s).

Associate Editor

Thank you for considering our journal for publication of your manuscript. Your manuscript has now been peer-reviewed, could you please take their comments into account and submit a revised version of your manuscript for our consideration?

Please submit your revised manuscript by Feb 06 2025 11:59PM.

1. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have revised our manuscript formatting to match these guidelines. In particular we have removed figures from the main document and now provide them as TIFF files.

2. Thank you for stating the following financial disclosure:

[The United States Environmental Protection Agency (EPA) through its Office of Research and Development (ORD) funded the research described here. This project was supported by appointments to the Internship/Research Participation Program at ORD and administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and U.S. EPA. J.P.S acknowledges funding support from the U.S. EPA in grant USEPA RD840027].

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf."

We have added financial disclosures for non-EPA authors. The financial disclosure provided is the standard preferred by the EPA Office of Research and Development. Several of the researchers are within the EPA ORD (the funder). The new funding statement reads:

The United States Environmental Protection Agency (U.S. EPA) through its Office of Research and Development (ORD) funded the research described here. This project was supported by appointments to the Internship/Research Participation Program at ORD and administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the United States Department of Energy and U.S. EPA. JPS acknowledges funding support from the U.S. EPA in grant USEPA RD840027. MWL is a consultant at Ramboll and declares no conflict of interest. XC is an employee of Inotiv, Inc. Her work on this project was funded with federal funds from the National Institute of Environmental Health Sciences, National Institutes of Health under Contract No. HHSN273201500010C.

3. Please expand the acronym “ U.S. EPA” (as indicated in your financial disclosure) so that it states the name of your funders in full.

This information should be included in your cover letter; we will change the online submission form on your behalf.

Done.

4. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards.

At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories.

The R package httk is available from Figshare at: https://doi.org/10.23645/epacomptox.6062791.v1

5. Please include captions for your Supporting Information files at the end of your manuscript, and

update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

We have revised our supporting information to include captions at the end of the manuscript.

Reviewer #1

This manuscript describes the integration and evaluation of new PBTK models into an existing R package (httk) in order to improve in vitro to in vivo extrapolation, which is critical for human health risk assessment. The manuscript is written exceptionally well with clear referals to case studies and model performance evaluations. The manuscript also addresses limitations of the existing package and the improvements that will be implemented by the authors. I do not have any major queries that would impact on the current standard of the manuscript and would therefore suggest acceptance of the manuscript without revision.

Thank you very much for the positive feedback.

Reviewer #2

This manuscript describes the process of adding new TK models to the httk R package. The topic is relevant, particularly given the increasing reliance on in vitro and in silico methods for chemical risk assessment.

• While the manuscript provides a valuable overview of httk and its functionalities, several major revisions are needed to enhance clarity, accessibility, and impact. Specifically, the manuscript needs to be more concise and focused on the practical aspects of model integration, with less emphasis on background information already available elsewhere.

• A more concrete and worked-through example is essential for readers to grasp the process.

Major Revisions

• Streamline the Introduction: The introduction is lengthy and contains substantial background on HTTK and risk assessment that could be condensed or removed. Focus on the specific gap this manuscript addresses – the need for clear guidelines on integrating new models into httk – and the benefits of doing so (e.g., community contributions, model standardization, improved reproducibility).

Thank you for the suggestions. We have shortened the introduction and eliminated redundant information wherever possible throughout the manuscript. Some of the contextual information (that is, the motivation for developing a transparent workflow) has been moved to the discussion.

• Simplify and Refocus the Results Section: The current results section blends model integration details with evaluation results. Separate these clearly. The re-evaluation of the Linakis et al. model is interesting but distracts from the core purpose of the manuscript. Either move this to a supplementary document or significantly shorten it, focusing on specific changes and their impact on RMSLE. Emphasize the practical implications of observed changes for model developers. The discussion of benchmark_httk() is more appropriate for the methods.

• Reorganize the Methods Section: The methods section is currently quite dense and difficult to follow. Reorganize it into more logical subsections with clear headings, following the steps of model integration described in Table 1. Each subsection should describe the specific tasks involved in that step, the relevant httk functions and data, and provide short, illustrative code examples where appropriate. Move the discussion of benchmark_httk() from the Results to the "Model Evaluation" subsection of the Methods.

Potentially divide into 1) Overview Table, 2) Models, Core Fucntionality,

We thank the reviewer for their suggestions. We have jointly addressed these two comments from the reviewer. We agree that there was room for improvement. We have reorganized the Methods and the Results sections to address the reviewer’s concerns about these sections. However, while having considered the reviewer’s recommendations, we propose a slightly different reorganization, since our goal is to help readers address everything that would be needed to get their model incorporated into the public release of httk.

The Methods is now organized into four main sections: 1) Creating and Integrating a New HTTK Model, 2) Core HTTK Functionality, 3) HTTK Data Library, and 4) Tools for HTTK Evaluation. Section one has been rearranged to closely follow the steps of Table 1 for adding a model. Sections 2-4 of the methods provide contextual descriptions of the methods and data that are available to model developers.

The Results section has been similarly reorganized. There are three sections, all of which use the inhalation PBTK model as an example. The first follows Table 1 and describes how a new model was added. A new Table 2 specifically identifies the files created and changes made for that model. Section 2 of the Results describe how the performance of that model was characterized – this is a prerequisite for incorporating any model into the public release of httk. The final section of results described how we determine if integration of the model has impacted performance of the rest of the httk package. We believe that this final section is important as part of the Results because developers of new models will be asked to characterize the impact of adding their model.

• Provide a Concrete, Worked-Through Example: The most significant weakness is the lack of a clear, step-by-step example. While the gas inhalation model is mentioned and supplementary files are provided, the manuscript doesn't guide the reader through the process of integration. Include a simplified, illustrative example within the main text, demonstrating the creation of a basic model (even a one-compartment model) and its integration into httk. Show concrete code snippets and explain the purpose of each step. This example should be the central focus of the manuscript.

Thank you for the suggestions. We have added a new table walking the users through the specific steps and files used to implement the inhalation PBTK model.

• Clarify the Role of MCSim: The manuscript mentions using MCSim for model description but doesn't clearly explain its advantages or provide enough guidance on its use. Expand this discussion and provide a simple MCSim example within the worked-through example mentioned above. If the authors intend to encourage MCSim use for new httk model contributions, this warrants more attention.

The reviewer’s point is well taken. In addition to the new Table 2 (which references the necessary steps including using MCSim), we have added the following discussion of MCSim to the Discussion:

Sophisticated computer programmers are not necessarily expert biological modelers, and vice versa.

There are significant computational advantages to using lower-level model implementations. For example, languages like C or Fortran can be compiled into assembly machine instructions that ran much more rapidly than interpreted languages like R. However, implementing biological models in compilable languages can be tricky. Biological modelers are often more comfortable with descriptive modeling languages which match human expectations (such as ACSL or Berkeley Madonna) rather than languages better suited for rapid computation [38]. Therefore, it is of great use that open source tools like MCSim [39] provide the ability to translate a descriptive language for models (that is, MCSim) into a rapid, compilable (C) language. A public domain guide to MCSim is available at: https://www.gnu.org/software/mcsim/mcsim.html

• Improve Table and Figure Presentation: Several tables are overly complex and could be simplified or broken down. Table 2, in particular, is very dense. Consider splitting it into smaller, more focused tables. Figures 3, 4, and 5 are helpful but could benefit from clearer labels and more concise captions.

We have thoroughly revised former table 2 (now table 3) so that it fits on a single page. We believe it is a critical part of the manuscript. It is intended to cross-walk between how aspects of a model are described in the three languages used by httk. We hesitate to break it into sub-tables because it will not serve its intended purpose if broken up.

We have increased the font sizes in Figure 3 and reduced the length of the captions for Figures 3, 4, and 5.

• Reduce Redundancy: There is some redundancy in the manuscript, particularly regarding the descriptions of core functions and data tables. Streamline these discussions and avoid repeating information already presented in the tables.

Wherever we could, we have reduced duplicative material.

• Clarify the Intended Audience: Is this manuscript intended for experienced modelers, R users, or a broader audience? Clarify the intended audience and adjust the level of detail and explanation accordingly.

We have revised the concluding paragraph of the introduction to hopefully clarify this:

This manuscript is an appeal to the biological modeling community to help expand the physiological and chemical domains addressed by httk. The model development philosophy for httk is create a suite of models, each covering specific exposure scenarios, rather than a single all-encompassing model. Details provided here are intended to aid developers of new models so they may integrate it with httk and use its existing data and functionality.

Minor Revisions:

• Carefully proofread the manuscript for typos and grammatical errors.

Thank you for the suggestion, multiple coauthors have checked for typos and grammar.

• Ensure consistency in terminology and abbreviations.

We have done our best.

• Provide more context and explanation for equations and mathematical concepts.

We have done our best.

• Double-check the accuracy of all URLs and references.

References and URLs have been checked.

• By addressing these major revisions, the manuscript can be significantly improved and provide a truly practical and accessible guide for integrating new TK models into httk, fostering community contributions and advancing the field of HTTK modeling

Reviewer #3

• Please remove the quote from the end of the Introduction section. While Dr Feynman is the best, and I absolutely love the quote itself, it seems out of place and unnecessary here.

Done.

• A lot of the Methods section feels like it belongs in the Supplementary section

While we have extensively reorganized the Methods section and reduced duplicative material to address concerns from other reviewers, we are hesitant to move too much material to the Supplement. This is intended to be a “how to” paper and we hope to provide sufficient detail in the main manuscript.

Reviewer #4

In their present work, Sarah et al. describe the integration and evaluation of new physiologically based toxicokinetic (PBTK) models into an open-source R package. The research is robust, the manuscript is well-structured, and the authors have meticulously detailed each step of the model development process. I would like to offer a few suggestions to further enhance the manuscript:

• Abstract: The abstract is quite lengthy. It would be beneficial to make it more concise while retaining the essential details.

We have rewritten and shortened the abstract

• It would be helpful if the authors could discuss whether a similar tool is available in other programming languages, such as Python.

It is certainly possible to use MCSim with Python (Lohitnavy et al., 2017) and it is also possible to use R package httk through Python using RPy for Python (Kapraun et al., 2017). However, as far as we know the only open source database of chemical-specific HTTK parameters is R package httk. Python package ctx-python (https://github.com/USEPA/ctx-python) allows retrieval of pre-computed predictions made with httk from the CompTox Chemicals Dashboard. We have added this point to the

Discussion:

While there is no reason HTTK data and models must be implemented in R, we are unaware of comparable tools in other, similar languages such as Python. It is certainly possible to use MCSim with Python [79] and it is also possible to use R package httk through

Attachments
Attachment
Submitted filename: Rebuttal Letter.docx
Decision Letter - Antonio Peña-Fernández, Editor

PONE-D-24-38287R1Enabling Transparent Toxicokinetic Modeling for Public Health Risk AssessmentPLOS ONE

Dear Dr. Wambaugh,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Thank you for submitting a revised version of your manuscript. Please can you re-submit the point by point answer to the reviewers so they can check your modifications?

==============================

Please submit your revised manuscript by Mar 26 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Antonio Peña-Fernández, PhD

Academic Editor

PLOS ONE

Additional Editor Comments:

Dear authors,

Thank you for submitting a revised version of your manuscript. Please can you re-submit the point by point answer to the reviewers so they can check your modifications?

Best wishes,

Antonio

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 2

Reviewer #1

This manuscript describes the integration and evaluation of new PBTK models into an existing R package (httk) in order to improve in vitro to in vivo extrapolation, which is critical for human health risk assessment. The manuscript is written exceptionally well with clear referals to case studies and model performance evaluations. The manuscript also addresses limitations of the existing package and the improvements that will be implemented by the authors. I do not have any major queries that would impact on the current standard of the manuscript and would therefore suggest acceptance of the manuscript without revision.

Thank you very much for the positive feedback.

Reviewer #2

This manuscript describes the process of adding new TK models to the httk R package. The topic is relevant, particularly given the increasing reliance on in vitro and in silico methods for chemical risk assessment.

• While the manuscript provides a valuable overview of httk and its functionalities, several major revisions are needed to enhance clarity, accessibility, and impact. Specifically, the manuscript needs to be more concise and focused on the practical aspects of model integration, with less emphasis on background information already available elsewhere.

• A more concrete and worked-through example is essential for readers to grasp the process.

Major Revisions

• Streamline the Introduction: The introduction is lengthy and contains substantial background on HTTK and risk assessment that could be condensed or removed. Focus on the specific gap this manuscript addresses – the need for clear guidelines on integrating new models into httk – and the benefits of doing so (e.g., community contributions, model standardization, improved reproducibility).

Thank you for the suggestions. We have shortened the introduction and eliminated redundant information wherever possible. Some of the contextual information (that is, the motivation for developing a transparent workflow) has been moved to the discussion.

• Simplify and Refocus the Results Section: The current results section blends model integration details with evaluation results. Separate these clearly. The re-evaluation of the Linakis et al. model is interesting but distracts from the core purpose of the manuscript. Either move this to a supplementary document or significantly shorten it, focusing on specific changes and their impact on RMSLE. Emphasize the practical implications of observed changes for model developers. The discussion of benchmark_httk() is more appropriate for the methods.

• Reorganize the Methods Section: The methods section is currently quite dense and difficult to follow. Reorganize it into more logical subsections with clear headings, following the steps of model integration described in Table 1. Each subsection should describe the specific tasks involved in that step, the relevant httk functions and data, and provide short, illustrative code examples where appropriate. Move the discussion of benchmark_httk() from the Results to the "Model Evaluation" subsection of the Methods.

Potentially divide into 1) Overview Table, 2) Models, Core Fucntionality,

We have jointly reorganized the Methods and the Results sections to address the reviewer’s concerns about these sections. We thank the reviewer for their suggestions. We agree that there was room for improvement. However, while having considered the reviewer’s recommendations, we propose a slightly different reorganization. Our goal is to help readers address everything that would be needed to get their model incorporated into the public release of httk.

The Methods is now organized into four main sections 1) Creating and Integrating a New HTTK Model, 2) Core HTTK Functionality, 3) HTTK Data Library, and 4) Tools for HTTK Evaluation. Section one has been rearranged to closely follow the steps of Table 1 for adding a model. Sections 2-4 of the methods provide descriptions of the methods and data that are available to model developers.

The Results section has been similarly reorganized. There are three sections all using the inhalation PBTK model as an example. The first follows Table 1 and describes how a new model was added. A new Table 2 specifically references the files created and changes made for that model. Section 2 of the Results describe how the performance of that model was characterized – this is a prerequisite for incorporating any model into the public release of httk. The final section of results described how we determine if integration of the model has impacted performance of the rest of the httk package. We believe that this final section is important as part of the Results because developers of new models will be asked to characterize the impact of adding their model.

• Provide a Concrete, Worked-Through Example: The most significant weakness is the lack of a clear, step-by-step example. While the gas inhalation model is mentioned and supplementary files are provided, the manuscript doesn't guide the reader through the process of integration. Include a simplified, illustrative example within the main text, demonstrating the creation of a basic model (even a one-compartment model) and its integration into httk. Show concrete code snippets and explain the purpose of each step. This example should be the central focus of the manuscript.

Thank you for the suggestions. We have added a new table walking the users through the specific steps and files used to implement the inhaltion PBTK model.

• Clarify the Role of MCSim: The manuscript mentions using MCSim for model description but doesn't clearly explain its advantages or provide enough guidance on its use. Expand this discussion and provide a simple MCSim example within the worked-through example mentioned above. If the authors intend to encourage MCSim use for new httk model contributions, this warrants more attention.

The reviewer’s point is well taken. In addition to the new Table 2 (which references the necessary steps including using MCSim), we have added the following discussion of MCSim to the Discussion:

Sophisticated computer programmers are not necessarily expert biological modelers, and vice versa. There are significant computational advantages to using lower-level model implementations. For example, languages like C or Fortran can be compiled into assembly machine instructions that ran much more rapidly than interpreted languages like R. However, implementing biological models in compilable languages can be tricky. Biological modelers are often more comfortable with descriptive modeling languages which match human expectations (such as ACSL or Berkeley Madonna) rather than languages better suited for rapid computation [38]. Therefore, it is of great use that open source tools like MCsim [39] provide the ability to translate a descriptive language for models (that is, MCSim) into a rapid, compilable (C) language. A public domain guide to MCSim is available at: https://www.gnu.org/software/mcsim/mcsim.html

• Improve Table and Figure Presentation: Several tables are overly complex and could be simplified or broken down. Table 2, in particular, is very dense. Consider splitting it into smaller, more focused tables. Figures 3, 4, and 5 are helpful but could benefit from clearer labels and more concise captions.

We have thoroughly revised former table 2 (now table 3) so that it fits on a single page. We believe it is a critical part of the manuscript. It is intended to cross-walk between how aspects of a model are described in the three languages used by httk. We hesitate to break it into sub-tables because it will not serve its intended purpose if broken up.

We have increased the font sizes in Figure 3 and reduced the captions for Figures 3, 4, and 5.

• Reduce Redundancy: There is some redundancy in the manuscript, particularly regarding the descriptions of core functions and data tables. Streamline these discussions and avoid repeating information already presented in the tables.

Wherever we could, we have reduced duplicative material.

• Clarify the Intended Audience: Is this manuscript intended for experienced modelers, R users, or a broader audience? Clarify the intended audience and adjust the level of detail and explanation accordingly.

We have revised the concluding paragraph of the introduction to hopefully clarify this:

We are inviting the biological modeling community to help expand the physiology and chemical domains addressed by httk. This work is intended to help the developers of new models use the existing HTTK data and functionality.

Minor Revisions:

• Carefully proofread the manuscript for typos and grammatical errors.

Thank you for the suggestions, multiple coauthors have checked for typos and grammar.

• Ensure consistency in terminology and abbreviations.

We have done our best.

• Provide more context and explanation for equations and mathematical concepts.

We have done our best.

• Double-check the accuracy of all URLs and references.

References and URLs have been checked.

• By addressing these major revisions, the manuscript can be significantly improved and provide a truly practical and accessible guide for integrating new TK models into httk, fostering community contributions and advancing the field of HTTK modeling

Thank you.

Reviewer #3

• Please remove the quote from the end of the Introduction section. While Dr Feynman is the best, and I absolutely love the quote itself, it seems out of place and unnecessary here.

Done.

• A lot of the Methods section feels like it belongs in the Supplementary section

While we have extensively reorganized the Methods section and reduced duplicative material to address concerns from other reviewers, we are hesitant to move too much material to the Supplement. This is intended to be a “how to” paper and we hope to provide sufficient detail in the main manuscript.

Reviewer #4

In their present work, Sarah et al. describe the integration and evaluation of new physiologically based toxicokinetic (PBTK) models into an open-source R package. The research is robust, the manuscript is well-structured, and the authors have meticulously detailed each step of the model development process. I would like to offer a few suggestions to further enhance the manuscript:

• Abstract: The abstract is quite lengthy. It would be beneficial to make it more concise while retaining the essential details.

We have rewritten and shortened the abstract.

• It would be helpful if the authors could discuss whether a similar tool is available in other programming languages, such as Python.

It is certainly possible to use MCSim with Python (Lohitnavy et al., 2017) and it is also possible to use R package httk through Python using RPy for Python (Kapraun et al., 2017). However, as far as we know the only open source database of chemical-specific HTTK parameters is R package httk. Python package ctx-python (https://github.com/USEPA/ctx-python) allows retrieval of pre-computed predictions made with httk from the CompTox Chemicals Dashboard. We have added this point to the Discussion:

While there is no reason HTTK data and models must be implemented in R, we are unaware of comparable tools in other, similar languages such as Python. It is certainly possible to use MCSim with Python [79] and it is also possible to use R package httk through Python using rpy2 [80] for Python [81]. However, as far as we know the only open-source database of chemical-specific HTTK parameters and models is R package httk. Python package ctx-python (https://github.com/USEPA/ctx-python) allows retrieval of pre-computed predictions made with httk from the CompTox Chemicals Dashboard [63]. R package ctxR [82] provides functionality similar to ctx-python for R.

• The resolution of Figure 2 is quite low. Replacing it with a higher-resolution image would significantly improve its clarity and visual appeal.

We have added a standalone copy of Figure 2 to the submission. The image is saved as a tiff file that we can provide to the journal at arbitrary resolution. We have doubled the resolution to 1200 x 800, but for the time being the version that builds in the PDF may show at lower than optimal resolution.

Attachments
Attachment
Submitted filename: Rebuttal Letter-021025.docx
Decision Letter - Antonio Peña-Fernández, Editor

Enabling Transparent Toxicokinetic Modeling for Public Health Risk Assessment

PONE-D-24-38287R2

Dear Dr. Wambaugh,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Antonio Peña-Fernández, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear authors,

Your revised manuscript has been peer-reviewed. The reviewers are satisfied with the changes you have made and I am recommending publication in our journal.

Congratulations,

Antonio

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I believe that the revised manuscript addresses all the concerns raised by the reviewers and has been significantly improved.

Reviewer #4: The authors have incorporated the suggested changes. Therefore, I recommend accepting the manuscript in its current form.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #2: Yes:  Xuehai Wang

Reviewer #4: No

**********

Formally Accepted
Acceptance Letter - Antonio Peña-Fernández, Editor

PONE-D-24-38287R2

PLOS ONE

Dear Dr. Wambaugh,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Antonio Peña-Fernández

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .